Physician profile

Brendan Johnson

Las Vegas, NV

NPI 1811923980

$5,641.00

in general payments reported to CMS, 2019-2025

7 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Entertainment$1,475.83
Food and Beverage$910.56
Education$498.37

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Keystone Dental INC. $2,028.55 2023-2024
Nobel Biocare USA $1,672.89 2019-2023 Nobelactive
Sirona Dental, INC. $1,500.00 2019
Dentsply Sirona INC $221.29 2019
Hu-Friedy Mfg. Co., LLC $126.64 2023
Implant Direct Sybron International LLC $63.91 2019
Biohorizons Implant Systems INC. $27.72 2023 Biohorizons

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Brendan Johnson

$5,641.00

in general payments reported 2019-2025

Years
2019-2024
Top company
Keystone Dental INC.

https://glasscript.com/doctor/1299596/brendan-johnson

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.